share_log

HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $6 Price Target

Benzinga ·  May 15 10:43

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment